Author:
Hoffman Keith B.,Dimbil Mo,Erdman Colin B.,Tatonetti Nicholas P.,Overstreet Brian M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference50 articles.
1. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med. 2003;18(1):57–60.
2. FDA. Follow-Up to the November 2009 Early Communication about an Ongoing Safety Review of Sibutramine, Marketed as Meridia. 2010. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm198206.htm . Accessed Feb 2014.
3. Charatan F. Bayer decides to withdraw cholesterol lowering drug. BMJ (Clin Res Ed). 2001;323(7309):359.
4. FDA. Safety Information: Vioxx (rofecoxib). 2002. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154520.htm . Accessed Feb 2014.
5. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA, J Am Med Assoc. 2002;287(17):2215–20.
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献